Hospital
Fayette Medical Center
Fayette Medical Center was paid $902K by Medicaid between Jan 2018 and Nov 2024, across 58 billing codes. Its largest line is 99283, emergency room visit (moderate) — 42% of everything it billed.
33Billing provider infoFAYETTE MEDICAL CENTER
FAYETTE, AL 35555
FAYETTE, AL 35555
33aNPI1851323836assigned 07/07/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$902K
24GClaims38,916
24DCodes billed58
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Alabama
Rank by total paid#47 of 77
Median peer was paid$1.13M
This provider vs. median0.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,389 | $148K | |
| 2019 | 6,687 | $144K | |
| 2020 | 4,834 | $97K | |
| 2021 | 6,410 | $153K | |
| 2022 | 4,314 | $121K | |
| 2023 | 4,052 | $127K | |
| 2024incomplete | 3,230 | $112K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 42% | 10,674 | 9,949 | $375K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 20% | 3,636 | 3,275 | $180K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 14% | 1,205 | 1,142 | $122K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.8% | 395 | 323 | $43K |
| 80053 | Comprehensive metabolic panel | 4.3% | 4,906 | 4,277 | $39K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.2% | 4,692 | 4,056 | $29K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.3% | 1,045 | 973 | $21K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.0% | 466 | 452 | $18K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.9% | 440 | 413 | $18K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 718 | 687 | $10K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.1% | 230 | 224 | $10K |
| 81001 | <1% | 1,972 | 1,750 | $6K |
46 more codes
| 87631 | <1% | 70 | $5K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 77 | $3K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 42 | $3K |
| 71045 | Radiologic examination, chest; single view | <1% | 710 | $2K |
| 80061 | Lipid panel | <1% | 135 | $2K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 278 | $2K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 391 | $2K |
| 87081 | <1% | 168 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 126 | $1K |
| 83735 | <1% | 273 | $1K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 47 | $1K |
| 85027 | <1% | 333 | $1K | |
| 82607 | <1% | 49 | $810.12 | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 13 | $778.61 |
| 83880 | <1% | 84 | $704.33 | |
| 84484 | <1% | 137 | $585.71 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 150 | $517.86 |
| 84439 | <1% | 48 | $472.63 | |
| 85610 | <1% | 175 | $349.46 | |
| 83605 | <1% | 76 | $336.30 | |
| 82553 | <1% | 14 | $291.85 | |
| 82550 | <1% | 30 | $251.11 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 252 | $218.96 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 113 | $178.93 |
| 85730 | <1% | 175 | $176.80 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 12 | $142.20 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 15 | $111.15 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,738 | $97.64 |
| 74018 | <1% | 17 | $79.38 | |
| 83690 | <1% | 20 | $56.56 | |
| 82150 | <1% | 18 | $56.49 | |
| 81025 | <1% | 16 | $53.57 | |
| 81003 | <1% | 29 | $49.35 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 174 | $49.20 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 18 | $43.40 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 16 | $40.62 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 95 | $17.85 |
| 84145 | <1% | 13 | $3.62 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 30 | $1.76 |
| 36415 | Collection of venous blood by venipuncture | 0% | 715 | $0.00 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 0% | 308 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 192 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 62 | $0.00 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 20 | $0.00 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 0% | 21 | $0.00 |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 42 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHINDMAN, KERI (PATIENT ACCCOUNTS DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| The DCH Healthcare Authority | Tuscaloosa, AL | $16.03M |
| The DCH Health Care Authority | Tuscaloosa, AL | $182K |
| Fayette Medical Center | Fayette, AL | $102.19 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.